Crossmark

Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study

Crossref DOI link: https://doi.org/10.1007/s00125-020-05243-z

Published Online: 2020-08-04

Published Print: 2020-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Luo, Shan https://orcid.org/0000-0003-3368-9935
Schooling, C. Mary https://orcid.org/0000-0001-9933-5887
Wong, Ian Chi Kei https://orcid.org/0000-0001-8242-0014
Au Yeung, Shiu Lun https://orcid.org/0000-0001-6136-1836
Funding

Funding for this research was provided by:

University of Hong Kong (*200008682.920006.20006.400.01)
License Information

Text and Data Mining valid from 2020-08-04

Version of Record valid from 2020-08-04
More Information

Article History

Received: 27 March 2020

Accepted: 17 June 2020

First Online: 4 August 2020

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below